A prospective, single‑center, non-randomized, single-arm study to evaluate the performance of the Sirolimus-eluting Collagen Implant in patients undergoing surgical creation of an AV graft

Trial Profile

A prospective, single‑center, non-randomized, single-arm study to evaluate the performance of the Sirolimus-eluting Collagen Implant in patients undergoing surgical creation of an AV graft

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Dec 2017

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Arteriovenous fistula; Peripheral arterial disorders
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 04 Dec 2017 New trial record
    • 17 Nov 2017 Results published in a Vascular Therapies company website (http://www.vasculartx.com/progress-to-date/).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top